Stroke Risk Ends Sickle-Cell Study ; Research Aimed at Ending Blood Transfusion Therapy

Summary

---

ATLANTA A study aimed at determining if some children with sickle-cell anemia could be weaned off blood transfusion therapy has been halted because two young patients who stopped getting the procedure suffered strokes and others developed a high chance of strokes.

The National Institutes of Health issued a clinical alert Sunday recommending that doctors continue using blood transfusions to reduce the risk of stroke among young sickle-cell patients, even though the treatment has its own risk.

See the full content of this document

Extract

---

Stroke Risk Ends Sickle-Cell Study ; Research Aimed at Ending Blood Transfusion Therapy

The study, called STOP II, was funded by the NIH's National Heart, Lung and Blood Institute and involved 23 U.S. medical centers a...

See the full content of this document

---